ГоловнаArchive of numbers2014Volume 22, issue 1(78)The infl uence of detox therapy on level of "average molecules" at the blood of the patients with catatonic schizophrenia
Title of the article The infl uence of detox therapy on level of "average molecules" at the blood of the patients with catatonic schizophrenia
Authors Rachkauskas Gennadii Stasysovych
Radionova Svitlana Ivanivna
In the section DIAGNOSTICS AND THERAPY OF MENTAL DISORDERS
Year 2014 Issue Volume 22, issue 1(78) Pages 88-90
Type of article Scientific article Index UDK 615.456-657.356.647.12 Index BBK -
Abstract Influence of detox and metabolic active preparation reamberin on concentration of „average molecules» (AV) at the blood of the patients with catatonic schizophrenia (CS) was studied. It is set that reamberin using is instrumental in achievement of normalization of AV concentration that dated liquidations clinical-biochemical „metabolic» intoxication syndrome. Based of this data it is possible to deem reamberin plugging in the complex of treatment the patients with CS.
Key words catatonic schizophrenia, reamberin, average molecules, treatment
Access to full text version of the article pdf download
Bibliography 1. Afanas'ev V.V. Clinical pharmacology of reamberin: manual for physicians. [Klinicheskaia farmakologiia reamberina:posobie dlia vrachei]. St.-Petersburg: 2005. 44 p.
2. Gromashevskaia L.L. Metabolic intoxication in the pathogenesis and diagnosis of pathological processes.. [Metabolicheskaia intoksikatsiia v patogeneze i diagnostike patologicheskikh protsessov]. Laboratornaia diagnostika-Laboratory diagnosis, 2006. No. 1. Pp. 3-13.
3. Gromashevskaia L.L. "Average molecule" as one of indicators of "metabolic intoxication" in the body. [«Srednie molekuly» kak odin iz pokazatelei «metabolicheskoi intoksikatsii» v organizme]. Ibid, 1997. No. 1. Pp. 11-16.
4. Kut'ko I.I., Mikhailov B.V., Tabachnikov S.I. Current approaches to the treatment of schizophrenia. [Sovremennye podkhody k lecheniiu shizofrenii]. Khar'kov:Oko Publ., 2002. 138 p.
5. Kut'ko I.I., Frolov V.M., Rachkauskas G.S. Estimation of efficiency of a new drug reamberin in correction of metabolic disorders in the treatment of patients with paranoid schizophrenia. [Otsenka effektivnosti novogo preparata reamberina v korrektsii metabolicheskikh rasstroistv pri lechenii bol'nykh paranoidnoi shizofreniei]. Vіsnik psikhіatrії ta psikhofarmakoterapії -The bulletin of psychiatry and psychopharmacotherapy, 2005. No. 2 (8). Pp. 59-64.
6. Kut'ko I.I., Frolov V.M., Rachkauskas G.S. New features in the correction of metabolic abnormalities in patients with schizophrenia. [Novye vozmozhnosti v korrektsii metabolicheskikh narushenii u bol'nykh shizofreniei]. Novosti meditsiny i farmakologii-News of medicine and pharmacology, 2005. No. 19 (179). Pp. 19-20.
7. Lapach S.N., Chubenko A.V., Babich P.N. Statistical methods in biomedical researches using Excel. [Statisticheskie metody v mediko- biologicheskikh issledovaniiakh s ispol'zovaniem Excel]. Kiev: «Morіon» Publ., 2000. 320 p.
8. Lapach S.N., Chubenko A.V., Babich P.N. Basic principles on the use of statistical methods in clinical trials. [Osnovnye printsipy primeneniia statisticheskikh metodov v klinicheskikh ispytaniiakh] Kiev: «Morіon» Publ., 2002. 160 p.
9. Nikolaichik V.V., Moin V.M., Kirkovskii V.V. Method of determining of "middle molecules." [Sposob opredeleniia «srednikh molekul»]. Laboratornoe delo- Laboratory work, 1991. No.
10. Pp. 13-18. 10. Piter B. Johns, Piter F. Bakli. Schizophrenia. [Shizofreniia]. Moscow: MEDpress-inform Publ., 2008. 192 p.
11. Radionova S.I., Rachkauskas G.S. Modern approaches to the treatment of severe forms of schizophrenia. [Sovremennye podkhody k lecheniiu tiazhelykh form shizofrenii]. Ukrainskii meditsinskii al'manakh-Ukrainian Medical Almanac, 2007. Vol. 10, no. 3. Pp. 116-122.
12. Rachkauskas G.S. Immune and metabolic disorders at patients with schizophrenia. [Immunnye i metabolicheskie narusheniia u bol'nykh shizofreniei]. Tavricheskii zhurnal psikhiatrii- Tavrichesky journal of psychiatry, 1999. Vol. 3, no. 1. Pp. 77-79.
13. Rachkauskas G. S., Radionova S.I. Reamberin influence on the state of cellular immunity in patients during rehabilitation after suffering an attack of febrile catatonia. Proceedings of the conference. [Vliianie reamberina na sostoianie kletochnogo immuniteta u bol'nykh v periode reabilitatsii posle perenesennogo napadeniia febril'noi katatonii. Problemy truda i sotsial'nykh tekhnologii v promyshlennom regione: teoriia i praktika: mater.Mezhdunarodnoi nauch.-prakt. konf. (Lugansk, 5-6 dekabria 2008 g.)]. Lugansk, 2008. Pp. 379-383. 14. Reamberin: instructions for clinical use of the drug. Approved by the order of the MOH of Ukraine № 138 of 10.11.2013. [Reamberin: instruktsiya dlya klinichnogo zastosuvannya preparatu. Zatverdzhena nakazom MOZ Ukrayini № 138 vid 10.11.2013 r.]
15. Usenko L.V., Mosentsev N.F., Kolomiets A.V. Reamberin in complex of intensive therapy of multiple organ dysfunction-failure: study guide. [Reamberin v komplekse intensivnoi terapii poliorgannoi disfunktsii-nedostatochnosti: metod. rekomendatsii]. Dnepropetrovsk, 2004. 36 p.
16. Snezhnevskii A.V. Schizophrenia. Series of lectures. [Shizofreniia. Tsikl lektsii]. Moscow: MEDpress-inform Publ., 2009. 160 p.
17. Tiganov A.S. Manual on psychiatry. [Rukovodstvo po psikhiatrii]. Moscow: Meditsina, 1999. 717 p.
18. Fink M. Catatonia from its creation to DSM-V: Considerations for ICD. Indian J. Psychiatry, 2011. Vol. 53 (3). Pp. 4-7.
19. Escobar R., Rios A., Montoya ID. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res., 2000. Vol. 49 (6). Рp. 423-429.